These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Novel Aspects in the Pathophysiology of Peripheral Vasculopathy in Systemic Sclerosis. Suliman YA; Distler O Curr Rheumatol Rev; 2013; 9(4):237-44. PubMed ID: 26932287 [TBL] [Abstract][Full Text] [Related]
5. Improvement of vascular endothelial function using the oral endothelin receptor antagonist bosentan in patients with systemic sclerosis. Sfikakis PP; Papamichael C; Stamatelopoulos KS; Tousoulis D; Fragiadaki KG; Katsichti P; Stefanadis C; Mavrikakis M Arthritis Rheum; 2007 Jun; 56(6):1985-93. PubMed ID: 17530638 [TBL] [Abstract][Full Text] [Related]
6. A new avenue in the pathogenesis of systemic sclerosis: the molecular interface between the endothelial and the nervous systems. Romano E; Rosa I; Fioretto BS; Guiducci S; Manetti M; Matucci-Cerinic M Clin Exp Rheumatol; 2019; 37 Suppl 119(4):133-140. PubMed ID: 31025932 [TBL] [Abstract][Full Text] [Related]
7. Pathophysiology and clinical consequences of Raynaud's phenomenon related to systemic sclerosis. Sunderkötter C; Riemekasten G Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii33-5. PubMed ID: 16987831 [TBL] [Abstract][Full Text] [Related]
8. Predictive value of vascular disease biomarkers for digital ulcers in systemic sclerosis patients. Silva I; Teixeira A; Oliveira J; Almeida I; Almeida R; Vasconcelos C Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S127-30. PubMed ID: 26242908 [TBL] [Abstract][Full Text] [Related]
9. Defective endothelially mediated pulmonary vasodilation in systemic sclerosis. Cailes J; Winter S; du Bois RM; Evans TW Chest; 1998 Jul; 114(1):178-84. PubMed ID: 9674467 [TBL] [Abstract][Full Text] [Related]
10. Vascular abnormalities in scleroderma. Herron GS; Romero LI Semin Cutan Med Surg; 1998 Mar; 17(1):12-7. PubMed ID: 9512101 [TBL] [Abstract][Full Text] [Related]
11. Two faces of the same coin: Raynaud phenomenon and digital ulcers in systemic sclerosis. Galluccio F; Matucci-Cerinic M Autoimmun Rev; 2011 Mar; 10(5):241-3. PubMed ID: 20863907 [TBL] [Abstract][Full Text] [Related]
12. The loss of endothelium-dependent vascular tone control in systemic sclerosis. Livi R; Teghini L; Generini S; Matucci-Cerinic M Chest; 2001 Feb; 119(2):672-3. PubMed ID: 11171770 [No Abstract] [Full Text] [Related]
13. Endothelial dysfunction in systemic sclerosis. Altorok N; Wang Y; Kahaleh B Curr Opin Rheumatol; 2014 Nov; 26(6):615-20. PubMed ID: 25191994 [TBL] [Abstract][Full Text] [Related]
14. Raynaud's phenomenon and vascular disease in systemic sclerosis. Generini S; Matucci Cerinic M Adv Exp Med Biol; 1999; 455():93-100. PubMed ID: 10599328 [TBL] [Abstract][Full Text] [Related]
16. Improved endothelial function after endothelin receptor blockade in patients with systemic sclerosis. Cardillo C; Schinzari F; Melina D; Mores N; Bosello S; Peluso G; Zoli A; Ferraccioli G Arthritis Rheum; 2009 Jun; 60(6):1840-4. PubMed ID: 19479828 [TBL] [Abstract][Full Text] [Related]
17. Endothelial dysfunction is present only in the microvasculature and microcirculation of early diffuse systemic sclerosis patients. Domsic RT; Dezfulian C; Shoushtari A; Ivanco D; Kenny E; Kwoh CK; Medsger TA; Champion HC Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-154-60. PubMed ID: 25372799 [TBL] [Abstract][Full Text] [Related]
18. Digital iontophoresis of vasoactive substances as measured by laser Doppler imaging--a non-invasive technique by which to measure microvascular dysfunction in Raynaud's phenomenon. Anderson ME; Moore TL; Lunt M; Herrick AL Rheumatology (Oxford); 2004 Aug; 43(8):986-91. PubMed ID: 15199217 [TBL] [Abstract][Full Text] [Related]